Objective: To evaluate the association between perioperative morbidity and prostate size in patients with benign prostatic obstruction treated with thulium:YAG vapoenucleation of the prostate (ThuVEP). Methods: 687 patients were prospectively analyzed. Prostate size was <40 ml in 196 (group A), 40-79 ml in 336 (group B) and ≥80 ml in 155 (group C) patients. Results: The mean prostate sizes were 27.94 ± 6.77, 54.38 ± 10.54 and 109.8 ± 28.31 ml for groups A, B and C, respectively (p < 0.001). Hemoglobin loss (g/dl) differed significantly among group A (1.09 ± 1.02), group B (1.28 ± 1.27) and group C (1.62 ± 1.49) (p < 0.001). The correlation between hemoglobin loss and prostate size was very weak in all patients (r = 0.13, p ≤ 0.001). Peak urinary flow rates and post-voiding residual urine improved significantly (p < 0.001) without differences among the groups. The incidence of complications was low and not different among the groups (acute urinary retention 8%, urinary tract infection 4.66%, secondary apical resection 2.91%, transfusion rate 2.03%). Conclusions: Perioperative morbidity and micturition improvement are not associated with prostate size in ThuVEP.

Keywords:
Benign prostatic obstruction, Vapoenucleation, Thulium:YAG vapoenucleation of the prostate, Morbidity
1.
Rassweiler J, Teber D, Kuntz R, Hofmann R: Complications of transurethral resection of the prostate (TURP) - incidence, management, and prevention. Eur Urol 2006;50:969-979, discussion 980.
2.
Tubaro A, de Nunzio C: The current role of open surgery in BPH. EAU-EBU Update Ser 2006;4:191-201.
3.
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG; Urology Section of the Bavarian Working Group for Quality Assurance: Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008;180:246-249.
4.
Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, Stief CG, Reich O: Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 2007;177:1419-1422.
5.
Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T: Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 2013;63:859-867.
6.
Kuntz RM, Lehrich K, Ahyai SA: Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 2008;53:160-168.
7.
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F: Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 2006;50:563-568.
8.
Kuntz RM, Lehrich K, Ahyai S: Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol 2004;18:183-188.
9.
Kuntz RM, Ahyai S, Lehrich K, Fayad A: Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004;172:1012-1016.
10.
Humphreys MR, Miller NL, Handa SE, Terry C, Munch LC, Lingeman JE: Holmium laser enucleation of the prostate - outcomes independent of prostate size? J Urol 2008;180:2431-2435.
11.
Shah HN, Sodha HS, Kharodawala SJ, Khandkar AA, Hegde SS, Bansal MB: Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int 2008;101:1536-1541.
12.
Bach T, Wendt-Nordahl G, Michel MS, Herrmann TRW, Gross AJ: Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 2009;27:541-545.
13.
Netsch C, Pohlmann L, Herrmann TR, Gross AJ, Bach T: 120-W 2-µm thulium:yttrium-aluminium-garnet vapoenucleation of the prostate: 12-month follow-up. BJU Int 2012;110:96-101.
14.
Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ: Thulium:YAG vapoenucleation in large volume prostates. J Urol 2011;186:2323-2327.
15.
Hauser S, Rogenhofer S, Ellinger J, Strunk T, Müller SC, Fechner G: Thulium laser (RevoLix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. Urol Int 2012;88:390-394.
16.
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG: Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58:384-397.
17.
Elzayat EA, Habib EI, Elhilali MM: Holmium laser enucleation of the prostate: a size-independent new ‘gold standard'. Urology 2005;66:108-113.
18.
Shah HN, Kausik V, Hegde S, Shah JN, Bansal MB: Evaluation of fluid absorption during holmium laser enucleation of prostate by breath ethanol technique. J Urol 2006;175:537-540.
19.
Elzayat EA, Elhilali MM: Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 2006;49:87-91.
20.
Matlaga BR, Kim SC, Kuo RL, Watkins SL, Lingeman JE: Holmium laser enucleation of the prostate for prostates of >125 mL. BJU Int 2006;97:81-84.
21.
Peterson MD, Matlaga BR, Kim SC, Kuo RL, Soergel TM, Watkins SL, Lingeman JE: Holmium laser enucleation of the prostate for men with urinary retention. J Urol 2005;174:998-1001.
22.
Shah HN, Mahajan AP, Hegde SS, Bansal MB: Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 2007;100:94-101.
23.
Lourenco T, Shaw M, Fraser C, MacLennan G, N'Dow J, Pickard R: The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials. World J Urol 2010;28:23-32.
24.
Kuntz RM: Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49:961-969.
25.
Placer J, Gelabert-Mas A, Vallmanya F, Manresa JM, Menéndez V, Cortadellas R, Arango O: Holmium laser enucleation of prostate: outcome and complications of self-taught learning curve. Urology 2009;73:1042-1048.
26.
Xiong W, Sun M, Ran Q, Chen F, Du Y, Dou K: Learning curve for bipolar transurethral enucleation and resection of the prostate in saline for symptomatic benign prostatic hyperplasia: experience in the first 100 consecutive patients. Urol Int 2013;90:68-74.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.